A Distinctive Metabolomics Profile and Potential Biomarkers for Very Long Acylcarnitine Dehydrogenase Deficiency (VLCADD) Diagnosis in Newborns
Very long-chain acylcarnitine dehydrogenase deficiency (VLCADD) is a rare inherited metabolic disorder associated with fatty acid <i>β</i>-oxidation and characterized by genetic mutations in the <i>ACADVL</i> gene and accumulations of acylcarnitines. VLCADD, developed in neon...
Main Authors: | Rajaa Sebaa, Reem H. AlMalki, Wafaa Alseraty, Anas M. Abdel Rahman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/13/6/725 |
Similar Items
-
Untargeted Metabolomics Identifies Biomarkers for MCADD Neonates in Dried Blood Spots
by: Rajaa Sebaa, et al.
Published: (2023-06-01) -
Very long‐chain acyl‐CoA dehydrogenase deficiency in a Swedish cohort: Clinical symptoms, newborn screening, enzyme activity, and genetics
by: David Olsson, et al.
Published: (2022-03-01) -
Combined HIIT and Resistance Training in Very Long-Chain Acyl-CoA Dehydrogenase Deficiency: A Case Report
by: Alba M. Herrera-Olivares, et al.
Published: (2019-05-01) -
Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency: Family Impact and Perspectives
by: Sarah Crawford, et al.
Published: (2023-10-01) -
Rhabdomyolysis in a neonate due to very long chain acyl CoA dehydrogenase deficiency
by: Jessica Scott Schwoerer, et al.
Published: (2015-06-01)